RegentAtlantic Capital’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$391K Sell
3,506
-200
-5% -$25.6K 0.01% 506
2022
Q2
$503K Sell
3,706
-257
-6% -$38.7K 0.02% 432
2022
Q1
$660K Sell
3,963
-310
-7% -$58.9K 0.02% 401
2021
Q4
$763K Sell
4,273
-225
-5% -$40.1K 0.02% 362
2021
Q3
$796K Sell
4,498
-849
-16% -$141K 0.02% 342
2021
Q2
$860K Sell
5,347
-1,787
-25% -$275K 0.03% 318
2021
Q1
$1.07M Sell
7,134
-2,897
-29% -$351K 0.04% 268
2020
Q4
$990K Buy
+10,031
New +$1M 0.04% 244

Other funds holding CNXC

RegentAtlantic Capital's CNXC Position: Q3 2022 in Review

RegentAtlantic Capital reduced its Concentrix (CNXC) stake by 5.4% in Q3 2022, selling an estimated $25.6K and leaving 3,506 shares worth $391K. The position accounts for 0.01% of the portfolio, ranked #506.

RegentAtlantic Capital first reported a position in CNXC in Q4 2020 and has held it in 8 quarters since. The position peaked at $1.07M in Q1 2021. 313 funds tracked by Wall St. Rank hold CNXC as of Q3 2022.

  • RegentAtlantic Capital held 3,506 shares of Concentrix worth $391K as of Q3 2022.
  • RegentAtlantic Capital sold 200 Concentrix shares in Q3 2022, an estimated $25.6K.
  • Concentrix made up 0.01% of RegentAtlantic Capital's portfolio in Q3 2022, its #506 holding.
  • RegentAtlantic Capital first reported a position in Concentrix in Q4 2020 and has held it in 8 quarters since.
  • RegentAtlantic Capital's Concentrix position peaked at $1.07M in Q1 2021.
  • 313 funds tracked by Wall St. Rank held Concentrix as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.